NCT01248546View on ClinicalTrials.gov

Tomosynthesis in the Oslo Breast Cancer Screening Program

UnknownOBSERVATIONAL
Enrollment

25,000

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

September 30, 2015

Conditions
Recall RateCancer Detection RateFalse Positive RatePositive Predictive Value
Interventions
PROCEDURE

Digital breast tomosynthesis

The participants included in the trial will have an additional radiation exposure for breast tomosynthesis

Trial Locations (1)

0407

Oslo University Hospital, Ulleval, Oslo

Sponsors

Collaborators (1)

Hologic, Inc.
All Listed Sponsors
collaborator

Norwegian Institute of Public Health

OTHER_GOV

collaborator

Hologic, Inc.

INDUSTRY

lead

Oslo University Hospital

OTHER

NCT01248546 - Tomosynthesis in the Oslo Breast Cancer Screening Program | Biotech Hunter | Biotech Hunter